Covaxin safe for children aged 2-18 years, says Bharat Biotech

Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that...

Covaxin found to be safe, immunogenic in 2-18 age group in...

Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday...

No data shows need for booster vaccines presently: Dr...

New Delhi [India], August 17 (ANI): Speaking about when a booster dose should be administered, Dr Gagandeep Kang,...

Plea in Delhi HC seeking stay on Phase II/III clinical trial...

New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the...

Two Indian vaccine candidates against COVID-19 in phase two...

New Delhi [India], Aug 29 (ANI): Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR...

World's first phase III clinical trial of COVID-19...

Abu Dhabi [UAE], July 16 (WAM/ANI): The first World Health Organisation (WHO) enlisted global clinical Phase III...

Panacea Biotec to collaborate with US-based Refana Inc for...

New Delhi [India], June 10 (ANI): Biotechnology major Panacea Biotec said on Wednesday it is collaborating with...

China's inactivated COVID-19 vaccine shows potent protection...

Beijing [China], June 9 (ANI): China's inactivated COVID-19 vaccine has shown protection against coronavirus...